RxDoctor Payments DataLook up a doctor →

RLX030A_INVESTIGATIONAL_CARDIOVASCULAR: payments to doctors

Payments that named RLX030A_INVESTIGATIONAL_CARDIOVASCULAR as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$45K
Providers
4
Transactions
32
Average per transaction
$1,403

The per-transaction average — $1,403 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4 providers the average total is $11,224, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Novartis Pharma AG$44,898100.0%
← All drugs & devices